Trials / Completed
CompletedNCT00663286
A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,399 (actual)
- Sponsor
- Dow Pharmaceutical Sciences · Industry
- Sex
- All
- Age
- 12 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDP-110 | Topical application for 12 weeks |
| DRUG | Clindamycin | Topical application for 12 weeks |
| DRUG | Benzoyl peroxide | Topical application for 12 weeks |
| DRUG | Vehicle | Topical application for 12 weeks |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2007-08-01
- First posted
- 2008-04-22
- Last updated
- 2008-04-22
Locations
33 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00663286. Inclusion in this directory is not an endorsement.